10x Genomics, Inc. (TXG) Revenue History
10x Genomics, Inc. (TXG) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2019-12-31 | $245.89M |
| 2020-12-31 | $298.85M |
| 2021-12-31 | $490.49M |
| 2022-12-31 | $516.41M |
| 2023-12-31 | $618.73M |
| 2024-12-31 | $610.78M |
| 2025-12-31 | $642.82M |
How TXG compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc. | $719.89M |
| RARE | Ultragenyx Pharmaceutical Inc. | $673.00M |
| AXSM | Axsome Therapeutics Inc. | $638.50M |
| TGTX | TG Therapeutics Inc. | $616.29M |
| AZTA | Azenta Inc. | $593.82M |
These are five companies in the same sector as TXG with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get 10x Genomics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("TXG", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TXG | $65.12 | +1.96% | 3.25M |
| 3 | ||||
| 4 | ||||
| 5 |